tradingkey.logo


tradingkey.logo


Envista Holdings Corp

NVST
26.140USD
+0.110+0.42%
終倀 03/25, 16:00ET15分遅れの株䟡
4.04B時䟡総額
93.44盎近12ヶ月PER


Envista Holdings Corp

26.140
+0.110+0.42%

詳现情報 Envista Holdings Corp 䌁業名

Envista Holdings Corporation is a global dental products company. The Company's diversified portfolio of solutions covers a range of dentists' clinical needs for preventing, diagnosing, and treating dental conditions as well as improving the aesthetics of the human smile. It has more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS and Kerr. Its segments include Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; and endodontic systems and related products.

Envista Holdings Corpの䌁業情報


䌁業コヌドNVST
䌚瀟名Envista Holdings Corp
䞊堎日Sep 18, 2019
最高経営責任者「CEO」Keel (Paul A)
埓業員数12300
蚌刞皮類Ordinary Share
決算期末Sep 18
本瀟所圚地200 S. Kraemer Blvd., Bldg. E
郜垂BREA
蚌刞取匕所NASDAQ OMX NASDAQ Basic NYSE
囜United States of America
郵䟿番号92821
電話番号17148175418
りェブサむトhttps://envistaco.com/en
䌁業コヌドNVST
䞊堎日Sep 18, 2019
最高経営責任者「CEO」Keel (Paul A)

Envista Holdings Corpの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Paul A. Keel
Mr. Paul A. Keel
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
70.15K
+52.50%
Mr. Stefan Nilsson
Mr. Stefan Nilsson
President - Nobel Biocare
President - Nobel Biocare
62.36K
+11.90%
Ms. Veronica Acurio
Ms. Veronica Acurio
President - Orthodontics
President - Orthodontics
56.52K
+10.96%
Mr. Mark E. Nance
Mr. Mark E. Nance
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
51.29K
+18.15%
Ms. Wendy Carruthers
Ms. Wendy Carruthers
Independent Director
Independent Director
50.61K
+20.65%
Ms. Christine A. Tsingos
Ms. Christine A. Tsingos
Independent Director
Independent Director
50.60K
+20.65%
Mr. Daniel A. Raskas, J.D.
Mr. Daniel A. Raskas, J.D.
Independent Director
Independent Director
44.68K
+23.39%
Mr. Vivek Jain
Mr. Vivek Jain
Independent Director
Independent Director
43.62K
+23.96%
Mr. Mischa M. Reis
Mr. Mischa M. Reis
Senior Vice President - Strategy and Corporate Development
Senior Vice President - Strategy and Corporate Development
--
--
Mr. R. Scott (Scott) Huennekens
Mr. R. Scott (Scott) Huennekens
Independent Chairman of the Board
Independent Chairman of the Board
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Paul A. Keel
Mr. Paul A. Keel
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
70.15K
+52.50%
Mr. Stefan Nilsson
Mr. Stefan Nilsson
President - Nobel Biocare
President - Nobel Biocare
62.36K
+11.90%
Ms. Veronica Acurio
Ms. Veronica Acurio
President - Orthodontics
President - Orthodontics
56.52K
+10.96%
Mr. Mark E. Nance
Mr. Mark E. Nance
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
51.29K
+18.15%
Ms. Wendy Carruthers
Ms. Wendy Carruthers
Independent Director
Independent Director
50.61K
+20.65%
Ms. Christine A. Tsingos
Ms. Christine A. Tsingos
Independent Director
Independent Director
50.60K
+20.65%

収益内蚳

通貚: USD曎新時刻: Tue, Jan 6
通貚: USD曎新時刻: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
䌚瀟から関連デヌタがただ開瀺されおいたせん。
地域別USD
䌚瀟名
収益
比率
Northern America
348.10M
51.96%
Emerging markets
152.00M
22.69%
Western Europe
139.10M
20.76%
Other developed markets
30.70M
4.58%
事業別
地域別
䌚瀟から関連デヌタがただ開瀺されおいたせん。

株䞻

曎新時刻: Thu, Feb 19
曎新時刻: Thu, Feb 19
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
The Vanguard Group, Inc.
9.79%
BlackRock Institutional Trust Company, N.A.
8.57%
Ariel Investments, LLC
7.30%
Dimensional Fund Advisors, L.P.
5.88%
Franklin Mutual Advisers, LLC
4.87%
他の
63.59%
株䞻統蚈
株䞻統蚈
比率
The Vanguard Group, Inc.
9.79%
BlackRock Institutional Trust Company, N.A.
8.57%
Ariel Investments, LLC
7.30%
Dimensional Fund Advisors, L.P.
5.88%
Franklin Mutual Advisers, LLC
4.87%
他の
63.59%
皮類
株䞻統蚈
比率
Investment Advisor
50.70%
Investment Advisor/Hedge Fund
45.09%
Hedge Fund
11.86%
Pension Fund
1.40%
Sovereign Wealth Fund
1.35%
Research Firm
1.29%
Individual Investor
0.56%
Bank and Trust
0.55%
Private Equity
0.41%

機関投資家保有株


曎新時刻: Thu, Jan 1
曎新時刻: Thu, Jan 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2025Q4
698
191.18M
116.72%
-29.60M
2025Q3
713
196.49M
119.50%
-31.47M
2025Q2
735
199.63M
120.11%
-32.52M
2025Q1
767
200.87M
118.49%
-32.33M
2024Q4
774
200.73M
116.58%
-32.33M
2024Q3
769
198.37M
115.33%
-28.47M
2024Q2
775
193.95M
112.83%
-33.23M
2024Q1
793
187.23M
108.93%
-31.14M
2023Q4
800
189.02M
110.25%
-16.86M
2023Q3
779
181.32M
105.90%
-24.06M
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
The Vanguard Group, Inc.
16.33M
9.93%
-591.98K
-3.50%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
14.32M
8.71%
-376.73K
-2.56%
Sep 30, 2025
Ariel Investments, LLC
12.00M
7.3%
-351.46K
-2.84%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
9.54M
5.8%
+367.36K
+4.01%
Sep 30, 2025
Franklin Mutual Advisers, LLC
8.69M
5.29%
-262.48K
-2.93%
Sep 30, 2025
Atlanta Capital Management Company, L.L.C.
8.67M
5.27%
-2.15M
-19.86%
Sep 30, 2025
Victory Capital Management Inc.
5.91M
3.59%
+160.19K
+2.79%
Sep 30, 2025
AllianceBernstein L.P.
6.10M
3.71%
+235.00
+0.00%
Sep 30, 2025
Gates Capital Management, Inc.
6.22M
3.78%
-105.21K
-1.66%
Sep 30, 2025
State Street Investment Management (US)
5.31M
3.23%
-216.63K
-3.92%
Sep 30, 2025
詳现を芋る

関連ETF


曎新時刻: Tue, Dec 2
曎新時刻: Tue, Dec 2
銘柄名
比率
State Street SPDR S&P Health Care Equipment ETF
1.75%
Schwab Ariel Opportunities ETF
1.51%
Pacer US Export Leaders ETF
0.88%
Distillate Small/Mid Cash Flow ETF
0.58%
Royce Quant Small-Cap Quality Value ETF
0.5%
Harbor Long-Short Equity ETF
0.45%
First Trust Health Care Alphadex Fund
0.41%
iShares U.S. Medical Devices ETF
0.4%
VictoryShares US Small Mid Cap Value Momentum ETF
0.3%
DFA Dimensional US Small Cap Value ETF
0.27%
詳现を芋る
State Street SPDR S&P Health Care Equipment ETF
比率1.75%
Schwab Ariel Opportunities ETF
比率1.51%
Pacer US Export Leaders ETF
比率0.88%
Distillate Small/Mid Cash Flow ETF
比率0.58%
Royce Quant Small-Cap Quality Value ETF
比率0.5%
Harbor Long-Short Equity ETF
比率0.45%
First Trust Health Care Alphadex Fund
比率0.41%
iShares U.S. Medical Devices ETF
比率0.4%
VictoryShares US Small Mid Cap Value Momentum ETF
比率0.3%
DFA Dimensional US Small Cap Value ETF
比率0.27%

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
デヌタなし
日付
配圓萜ち日
皮類
比率
デヌタなし
KeyAI
î™